NCT02261896View on ClinicalTrials.gov

Antibiotic Prophylaxis for Endoscopic Ultrasound Guided Fine Needle Aspiration of Pancreatic Cystic Lesions

PHASE4CompletedINTERVENTIONAL

Enrollment

226

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

July 31, 2018

Study Completion Date

July 31, 2018

Conditions

Pancreatic Cystic Lesion

Interventions

DRUG

Placebo

Evaluate usefullness of antibiotic prophylaxis

DRUG

Ciprofloxacin

Ciprofloxacine 400 mg intravenous one dose followed by ciprofloxacine oral each 12 hours (complete 3 days)

Trial Locations (1)

08025

Hospital de la Santa Creu i Sant Pau, Barcelona

All Listed Sponsors

collaborator

Spanish Clinical Research Network - SCReN

NETWORK

lead

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

OTHER

NCT02261896 - Antibiotic Prophylaxis for Endoscopic Ultrasound Guided Fine Needle Aspiration of Pancreatic Cystic Lesions | Biotech Hunter | Biotech Hunter